Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

Neuropsychopharmacology - United Kingdom
doi 10.1038/npp.2014.261
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Ketamine and Electroconvulsive Therapy Pairing in Depression and Mood Disorders

Psychiatry and Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2017English

Novel Therapeutics for Hemophilia and Other Bleeding Disorders

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Novel Treatment Approaches in Mood Disorders Chair: Gin Malhi

Bipolar Disorders
PsychiatryBiological PsychiatryMental Health
2019English

The American Invasion of Grenada: A Note on False Prophecy

Foresight
FinanceBusinessEconomicsInternational ManagementManagement ScienceInnovationManagement of TechnologyEconometricsOperations Research
2008English

Age and Remission of Personality Pathology in the Psychotic Disorders Compared to Mood and/or Anxiety Disorders

International Journal of Psychiatry in Medicine
PsychiatryMental Health
2012English

New Psychotherapies for Mood and Anxiety Disorders: Necessary Innovation or Waste of Resources?

Canadian Journal of Psychiatry
PsychiatryMental Health
2011English

Mood Disorders in Adolescents

English

Targeting DNA Replication and Repair for the Development of Novel Therapeutics Against Tuberculosis

Frontiers in Molecular Biosciences
BiochemistryGeneticsMolecular Biology
2017English

New Therapeutic Targets for Mood Disorders

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy